)
Vitrolife Group (VITR) investor relations material
Vitrolife Group Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved 6% organic growth in local currencies for Q4, excluding discontinued business, with strong performance in Americas and APAC regions, despite significant currency headwinds and macroeconomic challenges.
Full-year organic growth in local currencies, excluding discontinued business, was 4%.
Announced a major restructuring in Genetic Services, including discontinuation of two test lines, exit from low-profit markets, and impacting 6% of workforce.
Recorded a SEK 5,357 million goodwill impairment related to the Igenomix acquisition.
Financial highlights
Q4 sales were SEK 891 million, with 6% organic growth in local currencies, but a -10% impact from currency effects.
Adjusted gross margin for Q4 was 58.6%, down from 61.1% last year, mainly due to currency and regional mix.
Q4 adjusted EBITDA was SEK 251 million (28.2% margin); full-year adjusted EBITDA was SEK 1,004 million (29.2% margin).
Full-year sales reached SEK 3,440 million, with a 4% organic growth in local currencies and a 5% decrease in SEK due to currency effects.
Net income for the year was SEK -5,013 million (SEK 390 million excluding impairment and restructuring costs), with EPS at SEK 2.89 (excluding impairment and restructuring costs).
Operating cash flow for the year was SEK 635 million.
Outlook and guidance
Focus for 2026 is on growth, innovation, and operational excellence, with continued share gains in key markets and further leveraging the full portfolio.
R&D will prioritize impactful programs and further develop the IVF platform for automation and efficiency.
Investments in IT and digital capabilities are planned to improve customer experience and internal efficiency.
Expectation of market conditions returning to more normal levels in 2026, supporting profitable growth.
No formal guidance provided, but management anticipates normalization of gross margins to around 59% in 2026.
Next Vitrolife Group earnings date
Next Vitrolife Group earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)